Aligos Therapeutics (ALGS) Other Non-Current Assets (2021 - 2025)
Historic Other Non-Current Assets for Aligos Therapeutics (ALGS) over the last 5 years, with Q3 2025 value amounting to $713000.0.
- Aligos Therapeutics' Other Non-Current Assets rose 1228.35% to $713000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $713000.0, marking a year-over-year increase of 1228.35%. This contributed to the annual value of $627000.0 for FY2024, which is 32.0% up from last year.
- Per Aligos Therapeutics' latest filing, its Other Non-Current Assets stood at $713000.0 for Q3 2025, which was up 1228.35% from $640000.0 recorded in Q2 2025.
- Aligos Therapeutics' 5-year Other Non-Current Assets high stood at $1.6 million for Q1 2022, and its period low was $21000.0 during Q2 2022.
- Over the past 5 years, Aligos Therapeutics' median Other Non-Current Assets value was $627000.0 (recorded in 2024), while the average stood at $565894.7.
- In the last 5 years, Aligos Therapeutics' Other Non-Current Assets crashed by 8911.92% in 2022 and then soared by 140238.1% in 2024.
- Quarter analysis of 5 years shows Aligos Therapeutics' Other Non-Current Assets stood at $866000.0 in 2021, then dropped by 26.79% to $634000.0 in 2022, then fell by 1.42% to $625000.0 in 2023, then increased by 0.32% to $627000.0 in 2024, then grew by 13.72% to $713000.0 in 2025.
- Its Other Non-Current Assets stands at $713000.0 for Q3 2025, versus $640000.0 for Q2 2025 and $632000.0 for Q1 2025.